The new drug pipeline holds some promising therapies for lupus, according to Dr. Maureen McMahon, a rheumatologist at UCLA. But new drug development and FDA approval take time. Until then, lupus patients have Benlysta, the first drug to be approved for lupus in 50 years as well as the reliable, tried-and-true antimalarial drug hydroxychloroquine that has served them so well. This interview was conducted at the 5th Annual Perspectives in Rheumatic Diseases Seminar.